Change in renal heme oxygenase expression in cyclosporine A-induced injury

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 1, 2005, Pages 105-112

  Rezzani, Rita ^a   Rodella, Luigi ^a   Buffoli, Barbara ^a   Goodman, Alvin A ^b   Abraham, Nader G ^b   Lianos, Elias A ^c   Bianchi, Rossella ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Cyclosporine A; Heme oxygenase; Renal injury

Indexed keywords

CYCLOSPORIN A; ENDOTHELIN 1; HEME OXYGENASE 1; HEME OXYGENASE 2; HEME OXYGENASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MESOPORPHYRIN TIN; PORPHYRIN COBALT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; WESTERN BLOTTING;

ANIMALS; CYCLOSPORINE; ENDOTHELIN-1; ENZYME INDUCTION; FIBROSIS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; METALLOPORPHYRINS; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 12344280344     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6456.2005     Document Type: Article

References (37)

1. Abraham NG, Drummond GS, Lutton JD, Kappas A (1996) The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6:129-168
2. Ahmed A, Huang L, Raftery AT, Ahmed AK, Fahmy H, Nahas AM, Haylor JL (2004) Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia. Transplantation 77:686-692
3. Amore A, Emancipator SN, Cirina P, Conti G, Ricotti E, Bagheri N, Coppo R (2000) Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 57:1549-1559
4. Andoh TF, Gardner MP, Bennet WM (1997) Protective effect of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 64:1236-1240
5. Bantle JP, Paller MS, Boudreau RJ, Olivari MT, Ferris TF (1990) Long-term effects of cyclosporine on renal function in organ transplant recipients. J Lab Clin Med 115:233-240
6. Bianchi R, Rodella L, Rezzani R (2003) Cyclosporine A up-regulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. Int Immunopharmacol 3:427-433
7. Bloom IT, Bentley FR, Spain DA, Garrison RN (1995) An experimetal study of altered nitric oxide metabolism as a mechanism of cyclosporin-induced renal vasoconstriction. Br J Surg 82:195-198
8. Burke MD, Whiting PH (1986) The role of drug metabolism in cyclosporine A nephrotoxicity. Clin Nephrol 25:111-116
9. Da Silva JL, Zand BA, Yang LM, Sabaawy HE, Lianos EA, Abraham NG (2001) Heme oxygenase isoform-specific expression and distribution in the rat kidney. Kidney Int 59:1448-1457
10. Datta PK, Koukouritaki SB, Hopp KA, Lianos EA (1999) Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 10:2540-2550
11. Dekant W, Vanvakas S (1996) Biotransformation and membrane transport in nephrotoxicity. Crit Rev Toxicol 26:309-334
12. Jenkins JK, Huang H, Ndebele K, Salahudeen AK (2001) Vitamin E inhibits renal mRNA expression of COX II, HO I, TGFbeta, and osteopontin in the rat model of cyclosporine nephrotoxicity. Transplantation 71:331-334
13. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725-1738
14. Kim JY, Suh K (1995) Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Kor Med Sci 10: 352-359
15. Kim YJ, Park YH, Moon HK (1997) Reduction of chronic cyclosporin nephrotoxiciy by thromboxane synthase inhibition with OKY-046. Kidney Blood Press Res 20:38-43
16. Li C, Lim SW, Sun BK, Choi BS, Glowacka S, Cox A, Kelly D, et al. (2004) Expression of apoptosis-related factors in chronic cyclosporine nephrotoxicity after cyclosporine withdrawal. Acta Pharmacol Sin 25:401-411
17. Lim BJ, Kim PK, Hong SW, Jeong HJ (2004) Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity. Pediatr Nephrol 19:288-294
18. Mason J (1989) Pharmacology of cyclosporine VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 41:423-434
19. Mayer RD, Berman S, Cockett AT, Maines MD (1989) Differential effects of cyclosporin on hepatic and renal heme, cytochrome P-450 and drug metabolism. Possible role in nephrotoxicity of the drug. Biochem Pharmacol 38:1001-1007
20. Morimoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, Toma T, et al. (2001) Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney Int 60:1858-1866
21. Nast CC, Hirschberg R, Artishevsky A, Adler SG (1995) Misoprostol partially inhibits the renal scarring of chronic cyclosporine nephrotoxicity. Am J Ther 2:882-885.
22. Pahan K, Smith BT, Singh AK, Singh I (1997) Cytochrome P-450 2El in rat liver peroxisomes: downregulation by ischemia/reperfusion-induced oxidative stress. Free Radic Biol Med 23:963-971
23. Perico N, Benigni A, Zoja C, Delaini F, Remuzzi G (1986) Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. Am J Physiol 251:581-587
24. Quesniaux VE, Schreier MH, Wenger RM, Hiestand PC, Harding MW, Van Regenmortec RH (1987) Cyclophien binds to the region of cyclosporine involved in its immunosuppressive activity. Eur J Immunol 17:1359-1365
25. Rezzani R, Rodella L, Bianchi R (1999) Early metabolic changes in peripheral blood cells of renal transplant recipients treated with cyclosporine A. Int J Immunopharmacol 21:455-462
26. Rezzani R, Rodella L, Bianchi R (2001a) Induction of endothelin in rat kidney after cyclosporine A treatment. Acta Histochem 103: 423-431
27. Rezzani R, Rodella L, Corsetti G, Bianchi R (2001b) Does methylene blue protect the kidney tissues from damage induced by cyclosporine A treatment? Nephron 89:329-336
28. Rodicio JL (2000) Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients. J Cardiovasc Pharmacol 35:S7-11
29. Sabbatini M, Esposito C, De Nicola L, Uccello F, Altomonte M, Conte G, Dal Canton A, et al. (1989) Reversibility of acute cyclosporin nephrotoxicity by dopamine. Micropunture study in the rat. Nephrol Dial Transplant 4:327-333
30. Schaaf GJ, de Groene EM, Maas RF, Commandeur JNM, Fink-Gremmels J (2001) Characterization of biotransformation enzyme activities in primary rat proximal tubular cells. Chem Biol Interact 134:167-190
31. Taler SJ, Textor SC, Canzanello VJ, Schwartz L (1999) Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Safety 20:437-449
32. Textor SC, Canzanello VJ, Taler SJ, Wilson DJ, Schwartz LL, Augustine JE, Raymer JM, et al. (1994) Cyclosporine-induced hypertension after transplantation. Mayo Clin Proc 69:1182-1193
33. Torras J, Valles J, Sancez J, Sabate I, Jeron D, Carrera M, Castelao AM, et al. (1994) Prevention of experimental cyclosporine nephrotoxicity by dietary supplementation with LSL 90202, a lysine salt of eicosapentaenoic acid. Role of thromboxane and prostacyclin in renal tissue. Nephron 67:66-72
34. Verpooten GA, Wybo I, Pattyn VM, Hendrix PG, Giuliano RA, Nouwen EJ, Roels F, et al. (1986) Cyclosporine nephrotoxicity: comparative cytochemical study of rat kidney and human allograft biopsies. Clin Nephrol 25:S18-22
35. Wang C, Salahudeen AK (1995) Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E. Kidney Int 47: 927-934
36. Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P, Cordier A (1994) Role of glutathione in cyclosporine A in vitro hepatotoxicity. Transplant Proc 26:2912-2914
37. Zachariae H (1999) Renal toxicity of long-term cyclosporin. Scand J Rheumatol 28:65-68